Health-Related Quality of Life in Lung Cancer Survivors: Sociodemographic, Clinical, and Psychosocial Modulators
Current Oncology · 17.07.2026 · 33 (7) · 428
DOI: 10.3390/curroncol33070428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.07.2026. Verfasst von Yolanda Andreu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Personality, Assessment, and Psychological Treatments, Faculty of Psychology and Speech Therapy, University of Valencia, 46021 Valencia…. Hauptthemen laut MEDLINE: Quality of Life, Lung Neoplasms, Cancer Survivors. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The study aims to investigate the Health-Related Quality of Life (HRQOL) in lung cancer survivors, comparing it with the HRQOL of survivors of other types of cancer, analyzing its association with clinically significant distress, and exploring the modulating role of sociodemographic, clinical, and psychosocial variables. A total of 141 lung cancer survivors who had completed treatment with curative intent and were disease-free completed the Quality of Life in Adult Cancer Survivors questionnaire (QLACS), the Brief Symptom Inventory-18 (BSI-18), the Medical Outcomes Study–Social Support Survey (MOS-SSS), and the Utrecht Proactive Coping Competence scale (UPCC). Several multivariate analyses of variance (MANOVA) were performed to address the study objectives. Statistical analysis was performed using IBM SPSS Statistics 22.0. The overall HRQOL of lung cancer survivors did not differ from the HRQOL of hematologic, breast, and gynaecologic cancer survivors and was lower than that of colorectal, head/neck, prostate, and melanoma cancer survivors. HRQOL was associated with clinically significant distress. Younger age, female sex, lower levels of proactive coping, and less positive social interaction were independently associated with worse HRQOL in lung cancer survivors. The overall HRQOL of lung cancer survivors is among those with the poorest HRQOL compared with other cancer survivors’ groups. The modifiable nature of the psychosocial variables that characterize the risk profile (with the exception of sociodemographic ones) allows for the establishment of more ambitious goals than the simple establishment of subgroups on which to prioritize care. The team of professionals involved in the care of lung cancer survivors should also provide intervention strategies that improve their well-being.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Personality, Assessment, and Psychological Treatments, Faculty of Psychology and Speech Therapy, University of Valencia, 46021 Valencia, Spain.
- Department of Psychology and Sociology, Faculty of Social and Human Sciences of Teruel, University of Zaragoza, 44003 Teruel, Spain.
- Department of Oncology, Doctor Peset University Hospital, 46017 Valencia, Spain.
- Research Group INCUE, Valencia Health Department, Doctor Peset University Hospital, 46017 Valencia, Spain.
- Carena Association of Psycho-Oncology, Valencia Health Department, Doctor Peset University Hospital, 46017 Valencia, Spain.
ORCID-Profile: Ana Soto-Rubio, Beatriz Gil-Juliá, Carmen Picazo
Zitieren
APA
Andreu, Y., Soto-Rubio, A., Gil-Juliá, B., Picazo, C., Maestu, I., & Fernández, S. (2026). Health-Related Quality of Life in Lung Cancer Survivors: Sociodemographic, Clinical, and Psychosocial Modulators. Current Oncology, 33(7), 428. https://doi.org/10.3390/curroncol33070428
Vancouver
Andreu Y, Soto-Rubio A, Gil-Juliá B, Picazo C, Maestu I, Fernández S. Health-Related Quality of Life in Lung Cancer Survivors: Sociodemographic, Clinical, and Psychosocial Modulators. Current Oncology. 2026;33(7):428. doi:10.3390/curroncol33070428
BibTeX
@article{Andreu2026,
author = {Andreu, Yolanda and Soto-Rubio, Ana and Gil-Juliá, Beatriz and Picazo, Carmen and Maestu, Inmaculada and Fernández, Silvia},
title = {Health-Related Quality of Life in Lung Cancer Survivors: Sociodemographic, Clinical, and Psychosocial Modulators},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {7},
pages = {428},
doi = {10.3390/curroncol33070428}
}
EUVIMED